Carbohydrate tolerance and serum levels of insulin and C-peptide in patients after acute pancreatitis and with chronic pancreatitis;Odległe nastȩpstwa ostrego i przewleklego zapalenia trzustkiw zakresie wydzielania insuliny, peptydu C oraz tolerancji wȩglowodanów

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 6, 1996, Pages 561-569

  Zalewski, Leszek ^a,b  

^a Chorob Przemiany Materii AM w W ^*

^b Klinika Gastroenterologii i C   (Poland)

Author keywords

C peptide; Hepatic insulin clearance; Insulin; Pancreatitis

Indexed keywords

C PEPTIDE; DIAGNOSTIC AGENT; GLUCAGON; INSULIN;

ADULT; ARTICLE; BLOOD; CARBOHYDRATE DIET; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; MIDDLE AGED; PANCREATITIS; PATHOPHYSIOLOGY;

ADULT; C-PEPTIDE; CHRONIC DISEASE; DIETARY CARBOHYDRATES; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; PANCREATITIS;

EID: 2842585723     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dzieniszewski J., Gabryelewicz A.: Choroby trzustki. PZWL. Warszawa 1991.
2. Polonsky S., Rubenstein H.: C-peptide as a measure of secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes, 1984, 33, 486.
3. Imrie C.W., Benjamin I.S., Ferguson I.C.: A single-centre double-blind trial of trasylol therapy in acute pancreatitis. Brit J. Sug., 1987, 65, 337.
4. Sarner M., Colton P.B.: Classifications of pancreatits. International workshop., Gut. 1984, 25, 756.
5. WHO Expert Commitee on diabetes mellitus. Second Report. Technical Report Series 646. WHO, Geneva 1980.
6. Tai M.: A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care, 1994, 17, 152.
7. SAS Institut Inc., SAS (STAT Users Guide, Version 6, NC, USA, 1989, 1.
8. Szybinski Z., Popiela T., Sieradzki J., Labza H., Golda W.: Badania nad insulmemia u chorych po przebytym ostrym zapaleniu trzustki. Przegl. Lek., 1973, 30, 802.
9. Chyliński J., Wójcikowski Cz.: Wydzielanie insuliny u chorych po przebytym ostrym zapaleniu trzustki po doustnym obciażeniu glukoza. Pol. Tyg. Lek., 1975, 30, 2045.
10. Unger R.H., Grundy S.: Hyperglycaemia as an inducer as well as a concequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia, 1985, 28, 319.
11. Klöppel G., Bommer G., Philipp V., Heitz: Immunocytochemistry of the endocrine pancreas in chronic pancreatitis and pancreatic carcinoma. W: Secondary Diabetes: The spectrum of the diabetic syndromes, (red. H. Podolsky i M. Viswanathow, Reaven Press, New York, 1980, str. 147.
12. Yki-Jarvinen H., Kirilnoto T., Taskinen M-R.: Insulin resistance is a prominent feature of patients with pancreatopenic diabetes. Metabolism, 1986, 35, 718.
13. Yasuda H., Harano Y., Ohgaku S. i wsp.: Insulin sensitivity in pancreatitis, liver diseases, steroid treatment and hyper thyroidism assessed by glucose, insulin and somatostatin infusion. Horm. Metabol. Research, 1984, 16, 3.
14. Bajorunas D.R., Dresler C.M., Horowitz G.D., i wsp.: Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance. Diabetes, 1989, 35, 556.
15. Kalk W.J., Vinik A I., Bank S., Buchanan K.D., Keller P., Jacksom P.U : Glucagon responses to arginine in chronic pancreatitis. Diabetes, 1974, 23, 257.
16. Prato S., Riva F., Devide A., Nosadini R., Fedele D. Tiengo A.: Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis, Acta Diabetol Lat., 1980, 17, 111.
17. Persson I., Gyntelberg F., Heding L.G., Boss-Nielsen J., Pancreatic glucagon-like immunoreactivity after intravenous insulin in normals and chronic pancreatitis patients. Acta Endocrin., 1971, 67, 401.
18. Zander E., Lorenz D., Ziegler B. i wsp.: Relationship between insulin secretion and pancreas morphology in subjects with chronic pancreatitis. Horm. Metab. Research, 1984, 16, Supp. str. 149.
19. Bonora E., Rozzi C.,Lesi C., Berra P., Coscelli C., Butturini U.: Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia. Dig. Dis. Se., 1983, 33, 732.
20. Perusicowa J.: Glucose tolerance and secretion of insulin in chronic pancreatitis. Acta Universitatis Carolinae., Praha, 1989, 131, 36.
21. Grott J.W.: Dalsze losy chorych z przebytym ostrym zapaleniem trzustki. Pol. Arch. Med. Wewn., 1953, 23, 127.
22. Klöpel G., Maillet B.: Chronic pancreatitis evolution of the disease. Hepatogastroenterol., 1991, 38, 408.
23. Kasperska-Czyzykowa T.: Hormonalne uwarunkowama przemiany weglowodanowej w marskości watroby. Praca habilitacyjna, Akademia Medyczna w Warszawie, 1980.
24. Kasperska-Czyzykowa T., Chciuk-Górnicka M., Czerwińska A.: Zachowanie sic peptydu C w surowicy u chorych z. przewlektym zapaleniem trzustki. Pol. Arch. Med. Wewn., 1980, 63, 45.
25. Kasperska-Czyzykowa T., Heding L.G., Tronier B.: The serum concentration of insulin, C-peptide, and proinsulin in patients with acute pancreatitis. Int., J. Pancreatol. 1995, 17, 167.
26. Nagata A., Homma T., Ueno K. i wsp.: Sixteen years follow-up of a patient with alcoholic pancreatitis: serial findings of morphology and function on the pancreas and the liver. Gastroenterol. Jap., 1982, 17, 368.
27. Domschke S., Bloom S.R., Adrian T.E., Lux G., Domschke W.: Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides. Hepato-gastroenterology, 1988, 35, 229.
28. larsen S-, Hilsted J., Tronier B. and Warning H.: Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function. Acta Endocrin. 1988, 118, 357.